Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology（2023）
摘要
The data that support the findings of this study are available from the corresponding author upon reasonable request.
更多查看译文
关键词
exertional dyspneoa,severe allergic asthma,<scp>chronic obstructive pulmonary disease</scp>,omalizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要